AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014

Sep 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-09-24

Reporting Person: Goddard Glenn (Senior Vice President, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-24	Restricted stock units	$	A	10000	Acquired		Common stock (10000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2: All of the restricted stock units will vest on September 24, 2015. Vested shares will be delivered to the reporting person within three business days after such shares become vested.